{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:27:32Z","timestamp":1792445252085,"version":"4.5.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    (\n                    <jats:italic>H. pylori<\/jats:italic>\n                    ) is a Gram-negative anaerobic bacterium that colonizes the human stomach and is the leading cause of gastric diseases such as chronic gastritis and peptic ulcers, as well as the most definite and controllable risk factor for the development of gastric cancer. Currently, the regimen for\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication has changed from triple to quadruple, the course of treatment has been extended, and the type and dose of antibiotics have been adjusted, with limited improvement in efficacy but gradually increasing side effects and repeated treatment failures in an increasing number of patients. In recent years, probiotics have become one of the most important tools for supporting intestinal health and immunity. Numerous\n                    <jats:italic>in vitro<\/jats:italic>\n                    studies, animal studies, and clinical observations have demonstrated that probiotics have the advantage of reducing side effects and increasing eradication rates in adjuvant anti-\n                    <jats:italic>H. pylori<\/jats:italic>\n                    therapy and are a valuable supplement to conventional therapy. However, many different types of probiotics are used as adjuncts against\n                    <jats:italic>H. pylori<\/jats:italic>\n                    , in various combinations, with different doses and timing, and the quality of clinical studies varies, making it difficult to standardize the results. In this paper, we focus on the risk, status, prevention, control, and treatment of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection and review international consensus guidelines. We also summarize the available scientific evidence on using\n                    <jats:italic>Limosilactobacillus reuteri (L. reuteri)<\/jats:italic>\n                    as a critical probiotic for\n                    <jats:italic>H. pylori<\/jats:italic>\n                    treatment and discuss its clinical research and application from an evidence-based perspective.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2022.1042070","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:01:31Z","timestamp":1669341691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics"],"prefix":"10.3389","volume":"12","author":[{"given":"Bing","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ming","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jgar.2018.03.005","article-title":"Helicobacter pylori therapy and clinical perspective","volume":"14","author":"Abadi","year":"2018","journal-title":"J. Glob. Antimicrob. Re."},{"key":"B2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2010.02.021","article-title":"Detection of helicobacter pylori and clarithromycin resistance in gastric biopsies of pediatric patients by using a commercially available real-time polymerase chain reaction after NucliSens semiautomated DNA extraction","volume":"67","author":"Agudo","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12386","article-title":"Survival of helicobacter pylori in gastric acidic territory","volume":"22","author":"Ansari","year":"2017","journal-title":"Helicobacter"},{"key":"B4","first-page":"82","article-title":"Evidence base of lactobacillus reuteri efficacy in the treatment of diseases associated with helicobacter pylori","volume":"8","author":"Bordin","year":"2016","journal-title":"Experimental Clin. Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40795-018-0257-4","article-title":"The effect of lactobacillus reuteri supplementation in helicobacter pylori infection: a placebo-controlled, single-blind study","volume":"4","author":"Buckley","year":"2018","journal-title":"BMC Nutr."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.914418","article-title":"The interactions between oral-gut axis microbiota and helicobacter pylori","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: Treatment of helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of gastroenterology guideline on the management of helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"B9","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process\u2013first American cancer society award lecture on cancer epidemiology and prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12859","article-title":"Genome-wide mRNA-miRNA profiling uncovers a role of the microRNA miR-29b-1-5p\/PHLPP1 signalling pathway in helicobacter pylori-driven matrix metalloproteinase production in gastric epithelial cells","volume":"20","author":"Datta","year":"2018","journal-title":"Cell Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3409820","DOI":"10.1155\/2019\/3409820","article-title":"Role of probiotics in helicobacter pylori eradication: Lessons from a study of lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus(R)) and a proton-pump inhibitor","volume":"2019","author":"Dore","year":"2019","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore","year":"2016","journal-title":"Gut"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"And safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications","volume":"18","author":"EaY Tshibangu-Kabamba","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.953718","article-title":"The interplay between helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis","volume":"12","author":"Fakharian","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/17474124.2018.1496017","article-title":"Helicobacter pylori drug resistance: therapy changes and challenges","volume":"12","author":"Flores-Trevino","year":"2018","journal-title":"Expert Rev. Gastroent."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-pacific consensus guidelines for helicobacter pylori infection","volume":"24","author":"Fock","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"Ford","year":"2020","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0140-6736(94)91034-0","article-title":"H pylori and gastric cancer","volume":"343","author":"Forman","year":"1994","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-019-0515-z","article-title":"Upregulation of MUC5AC production and deposition of LEWIS determinants by HELICOBACTER PYLORI facilitate gastric tissue colonization and the maintenance of infection","volume":"26","author":"Gonciarz","year":"2019","journal-title":"J. BioMed. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1651-2227.2005.tb01848.x","article-title":"Effect of regular ingestion of saccharomyces boulardii plus inulin or lactobacillus acidophilus LB in children colonized by helicobacter pylori","volume":"94","author":"Gotteland","year":"2005","journal-title":"Acta Paediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.gtc.2015.05.003","article-title":"How to effectively use bismuth quadruple therapy: The good, the bad, and the ugly","volume":"44","author":"Graham","year":"2015","journal-title":"Gastroenterol. Clin. North Am."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/gutjnl-2019-319696","article-title":"Effect of helicobacter pylori on gastrointestinal microbiota: a population-based study in linqu, a high-risk area of gastric cancer","volume":"69","author":"Guo","year":"2020","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.micpath.2018.10.039","article-title":"The role of transferrin receptor in the helicobacter pylori pathogenesis; l-ferritin as a novel marker for intestinal metaplasia","volume":"126","author":"Hamedi Asl","year":"2019","journal-title":"Microb. Pathog."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01973-18","article-title":"Helicobacter pylori biofilm involves a multigene stress-biased response, including a structural role for flagella","volume":"9","author":"Hathroubi","year":"2018","journal-title":"mBio"},{"key":"B27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12602-014-9181-3","article-title":"Significant reduction in helicobacter pylori load in humans with non-viable lactobacillus reuteri DSM17648: A pilot study","volume":"7","author":"Holz","year":"2015","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10644","DOI":"10.3748\/wjg.v21.i37.10644","article-title":"Are probiotics useful in helicobacter pylori eradication","volume":"21","author":"Homan","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of helicobacter pylori infection: Systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031136","article-title":"Using probiotics as supplementation for helicobacter pylori antibiotic therapy","volume":"21","author":"Ji","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1073\/pnas.1808393115","article-title":"Acid-responsive activity of the helicobacter pylori metalloregulator NikR","volume":"115","author":"Jones","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.celrep.2016.01.017","article-title":"Gastric helicobacter pylori infection affects local and distant microbial populations and host responses","volume":"14","author":"Kienesberger","year":"2016","journal-title":"Cell Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15406\/ghoa.2020.11.00407","article-title":"Gastric microbiota and probiotics opportunities in helicobacter pylori eradication in children","volume":"11","author":"Kornienko","year":"2020","journal-title":"Gastroenterol Hepatol Open Access"},{"key":"B35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study","volume":"1","author":"Lind","year":"1996","journal-title":"Helicobacter"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"44935","DOI":"10.1038\/srep44935","article-title":"Alterations in gastric microbiota after h. pylori eradication and in different histological stages of gastric carcinogenesis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.3748\/wjg.v24.i40.4565","article-title":"Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression","volume":"24","author":"Liu","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1002\/jcph.1121","article-title":"Probiotics in disease prevention and treatment","author":"Liu","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12475","article-title":"Fifth Chinese national consensus report on the management of helicobacter pylori infection","volume":"23","author":"Liu","year":"2018","journal-title":"Helicobacter"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.3892\/mmr.2018.9558","article-title":"Helicobacter pylori infection enhances heparanase leading to cell proliferation via mitogenactivated protein kinase signalling in human gastric cancer cells","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/INF.0000000000001383","article-title":"Characterization of the gastric microbiota in a pediatric population according to helicobacter pylori status","volume":"36","author":"Llorca","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of helicobacter pylori infection: the maastricht III consensus report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of helicobacter pylori infection\u2013the maastricht IV\/ Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"B46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of helicobacter pylori infection-the maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.micpath.2018.08.033","article-title":"Alterations in metabolic pathways in gastric epithelial cells infected with helicobacter pylori","volume":"124","author":"Matsunaga","year":"2018","journal-title":"Microb. Pathog."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12529","article-title":"Probiotic supplementation with lactobacillus plantarum and pediococcus acidilactici for helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial","volume":"23","author":"Mcnicholl","year":"2018","journal-title":"Helicobacter"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.3390\/nu5083062","article-title":"Non-viable lactobacillus reuteri DSMZ 17648 (Pylopass) as a new approach to helicobacter pylori control in humans","volume":"5","author":"Mehling","year":"2013","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.31925\/farmacia.2019.5.17","article-title":"Lactobacillus reuteri \u2013 an alternatie in the first-line in helicobacrer pylori eradication","volume":"67","author":"Mihai","year":"2019","journal-title":"FARMACIA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/hel.12386","article-title":"Update on the adverse effects of antimicrobial therapies in community practice","volume":"66","author":"Mohsen","year":"2020","journal-title":"Can. Fam. Physician"},{"key":"B52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.15386\/mpr-1375","article-title":"Lactobacillus reuteri versus triple therapy for the eradication of helicobacter pylori in functional dyspepsia","volume":"92","author":"Muresan","year":"2019","journal-title":"Med. Pharm. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn311367-20210219-00108","article-title":"Expert consensus on the prevention, control and management of helicobacter pylori infection in Chinese households (2021)","volume":"41","year":"2021","journal-title":"Chin. J. Digest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.14309\/ajg.0000000000001246","article-title":"Adverse event profile during the treatment of helicobacter pylori: A real-world experience of 22,000 patients from the European registry on h. pylori management (Hp-EuReg)","volume":"116","author":"Nyssen","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrgastro.2016.195","article-title":"Population screening and treatment of helicobacter pylori infection","volume":"14","author":"O'connor","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B56","first-page":"1339","article-title":"An innovative approach in the treatment of H. pylori infection in children","volume":"22","author":"Parolova","year":"2015","journal-title":"RMJ"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i52b33611","article-title":"Efficacy of lactobacillus reuteri supplementation in eradication of h. pylori: A comparison study with triple drug therapy","author":"Parth","year":"2021","journal-title":"J. Pharm. Res. Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00253-018-09580-3","article-title":"Probiotic therapy in helicobacter pylori infection: a potential strategy against a serious pathogen","volume":"103","author":"Qureshi","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/14756366.2018.1539716","article-title":"Identification and characterization of the alpha-CA in the outer membrane vesicles produced by helicobacter pylori","volume":"34","author":"Ronci","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.gastro.2018.09.050","article-title":"Tropism for spasmolytic polypeptide-expressing metaplasia allows helicobacter pylori to expand its intragastric niche","volume":"156","author":"Saenz","year":"2019","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in helicobacter pylori: A systematic review and meta-analysis in world health organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2018.02.044","article-title":"The human gut microbiome: From association to modulation","volume":"172","author":"Schmidt","year":"2018","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e15180","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating helicobacter pylori: A network meta-analysis","volume":"98","author":"Shi","year":"2019","journal-title":"Med. (Baltimore)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/15321819.2018.1529683","article-title":"Neuroimmune crosstalk in helicobacter pylori infection: analysis of substance p and vasoactive intestinal peptide expression in gastric enteric nervous system","volume":"39","author":"Sticlaru","year":"2018","journal-title":"J. Immunoassay Immunochem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto Global consensus report on helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"B69","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B70","first-page":"3","article-title":"Evolution in eradication therapy of hp-associated diseases: beyond the standards","volume":"17","author":"Uspienskiy","year":"2016","journal-title":"RMJ"},{"key":"B71","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12866-018-1230-8","article-title":"Helicobacter pylori infection downregulates duodenal CFTR and SLC26A6 expressions through TGFbeta signaling pathway","volume":"18","author":"Wen","year":"2018","journal-title":"BMC Microbiol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12856","article-title":"Effects of non-viable lactobacillus reuteri combining with 14-day standard triple therapy on helicobacter pylori eradication: A randomized double-blind placebo-controlled trial","volume":"26","author":"Yang","year":"2021","journal-title":"Helicobacter"},{"key":"B73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jtcm.2018.02.008","article-title":"Effect of modified sanhuang xiexin tang plus additional herbs combined with \u201cstandard triple therapy\u201d on helicobacter pylori eradication","volume":"38","author":"Yao X.J","year":"2018","journal-title":"J. Tradit. Chin. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jsb.2018.08.017","article-title":"Structural flexibility in the helicobacter pylori peptidyl-prolyl cis,trans-isomerase HP0175 is achieved through an extension of the chaperone helices","volume":"204","author":"Yaseen","year":"2018","journal-title":"J. Struct. Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/hel.12217","article-title":"Intrafamilial, preferentially mother-to-Child and intraspousal, helicobacter pylori infection in Japan determined by mutilocus sequence typing and random amplified polymorphic DNA fingerprinting","volume":"20","author":"Yokota","year":"2015","journal-title":"Helicobacter"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223309","article-title":"Efficacy of lactobacillus-supplemented triple therapy for h. pylori eradication: A meta-analysis of randomized controlled trials","volume":"14","author":"Yu","year":"2019","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line helicobacter pylori therapy","volume":"64","author":"Zhang","year":"2015","journal-title":"Gut"},{"key":"B78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/00365521.2019.1591499","article-title":"The relationship between gastric microbiota and gastric disease","volume":"54","author":"Zhang","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.13288\/j.11-2166\/r.2020.22.019","article-title":"Expert consensus on joint diagnosis and treatment of gastritis caused by helicobacter pylori in adults (2020, Beijing)","volume":"61","author":"Zhang","year":"2020","journal-title":"J. Tradit. Chin. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"104403","DOI":"10.1016\/j.micpath.2020.104403","article-title":"Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of h. pylori and incidence of therapy-associated side effects","volume":"147","author":"Zhang","year":"2020","journal-title":"Microb. Pathog."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12651","article-title":"Saccharomyces boulardii as an adjuvant therapy for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis","volume":"24","author":"Zhou","year":"2019","journal-title":"Helicobacter"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1042070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:01:38Z","timestamp":1669341698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1042070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":81,"alternative-id":["10.3389\/fcimb.2022.1042070"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1042070","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"article-number":"1042070"}}